Compounds > deoxyfructosazine
Page last updated: 2024-11-06

deoxyfructosazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Deoxyfructosazine is a yellow, crystalline compound formed during the Maillard reaction between reducing sugars and amino acids. It is a potent antioxidant with potential therapeutic benefits, including anti-inflammatory and anticancer activities. The compound has been studied extensively due to its presence in various food products and its biological activities. Its synthesis is achieved through various methods, including enzymatic reactions and chemical processes. Deoxyfructosazine is also known to interact with proteins and enzymes, potentially influencing their functions.'

deoxyfructosazine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73452
SCHEMBL ID6871599
MeSH IDM0190550

Synonyms (15)

Synonym
17460-13-8
deoxyfructosazine
1,2,3,4-butanetetrol, 1-(5-(2,3,4-trihydroxybutyl)pyrazinyl)-, (1r-(1r*(2s*,3r*),2s*,3r*))-
nsc 270912
1,2,3,4-butanetetrol,1-[5-[(2s,3r)-2,3,4-trihydroxybutyl]-2-pyrazinyl]-, (1r,2s,3r)-
(1r,2s,3r)-1-[5-[(2s,3r)-2,3,4-trihydroxybutyl]-2-pyrazinyl]-1,2,3,4-butanetetrol
2,5-deoxyfructosazine
SCHEMBL6871599
DTXSID90169857
AKOS030241605
J-011017
FBDICDJCXVZLIP-VSSNEEPJSA-N
(1r,2s,3r)-1-(5-((2s,3r)-2,3,4-trihydroxybutyl)pyrazin-2-yl)butane-1,2,3,4-tetraol
AS-79286
PD007542
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
pyrazines
Pyrazines: A heterocyclic aromatic organic compound with the chemical formula C4H4N2.. pyrazine : A diazine that is benzene in which the carbon atoms at positions 1 and 4 have been replaced by nitrogen atoms.		3.1350diazine;
pyrazines		Daphnia magna metabolite
tagatosazine
tagatosazine: RN given refers ot (D-lyxo)-isomer; RN for cpd without isomeric designation not available 6/89		2.7330
glucosamine
D-glucosamine : An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.. 2-amino-2-deoxy-D-glucopyranose : A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2.		7.7830D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
4-vinylphenyl boronic acid
4-vinylphenyl boronic acid: structure in first source		2.0710
ConditionIndicatedRelationship StrengthStudiesTrials